Chapter 2604 Primary Candidate
- Soon, Nathan and Garrett were the only ones left inside the room.
- “Now that there are no outsiders, we can finally talk without holding back. Answer me truthfully, Nathan. How high are the chances of Cross Group's drug treating kidney cancer?” Garrett asked.
- “The drug's development is yet to be completed, but its effects are obvious. It is capable of treating kidney cancer in the early stages with ease, and there will be no recurrence. Since your cancer is in the later stages, treating it will be a lot more difficult. As my wife has told you earlier, the chances are about sixty percent.”